1. Apomorphine sublingual film for off episodes in Parkinson's disease: a randomised, double-blind, placebo-controlled phase 3 study. Issue 2 (February 2020) Authors: Olanow, C Warren; Factor, Stewart A; Espay, Alberto J; Hauser, Robert A; Shill, Holly A; Isaacson, Stuart; Pahwa, Rajesh; Leinonen, Mika; Bhargava, Parul; Sciarappa, Ken; Navia, Bradford; Blum, David Journal: Lancet neurology Issue: Volume 19:Issue 2(2020) Page Start: 135 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Initial choice of medication has little effect on short-term or long-term outcome for most patients with Parkinson's disease. Issue 1 (18th December 2014) Authors: Hauser, Robert A Journal: Evidence-based medicine Issue: Volume 20:Issue 1(2015) Page Start: 17 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. IPX066: a novel carbidopa–levodopa extended-release formulation. (February 2012) Authors: Hauser, Robert A Journal: Expert review of neurotherapeutics Issue: Volume 12:Number 2(2012) Page Start: 133 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. IPX066: a novel carbidopa–levodopa extended-release formulation. (February 2012) Authors: Hauser, Robert A Journal: Expert review of neurotherapeutics Issue: Volume 12:Number 2(2012) Page Start: 133 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. IPX066: a novel carbidopa–levodopa extended-release formulation. (February 2012) Authors: Hauser, Robert A Journal: Expert review of neurotherapeutics Issue: Volume 12:Number 2(2012) Page Start: 133 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Safety and efficacy of continuous subcutaneous foslevodopa-foscarbidopa in patients with advanced Parkinson's disease: a randomised, double-blind, active-controlled, phase 3 trial. Issue 12 (December 2022) Authors: Soileau, Michael J; Aldred, Jason; Budur, Kumar; Fisseha, Nahome; Fung, Victor SC; Jeong, Anna; Kimber, Thomas E; Klos, Kevin; Litvan, Irene; O'Neill, Daniel; Robieson, Weining Z; Spindler, Meredith A; Standaert, David G; Talapala, Saritha; Vaou, Eleni Okeanis; Zheng, Hui; Facheris, Maurizio F; H... Journal: Lancet neurology Issue: Volume 21:Issue 12(2022) Page Start: 1099 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Long-term safety and efficacy of deutetrabenazine for the treatment of tardive dyskinesia. Issue 12 (10th July 2019) Authors: Fernandez, Hubert H; Stamler, David; Davis, Mat D; Factor, Stewart A; Hauser, Robert A; Jimenez-Shahed, Joohi; Ondo, William G; Jarskog, L Fredrik; Woods, Scott W; Bega, Danny; LeDoux, Mark S; Shprecher, David R; Anderson, Karen E Journal: Journal of neurology, neurosurgery and psychiatry Issue: Volume 90:Issue 12(2019) Page Start: 1317 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Clinical utility of dopamine transporter single photon emission CT (DaT-SPECT) with (123I) ioflupane in diagnosis of parkinsonian syndromes. Issue 11 (13th March 2013) Authors: Bajaj, Nin; Hauser, Robert A; Grachev, Igor D Journal: Journal of neurology, neurosurgery and psychiatry Issue: Volume 84:Issue 11(2013) Page Start: 1288 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. 0617 Solriamfetol Treatment of Excessive Daytime Sleepiness in Parkinson's Disease: Results from a Phase 2 Proof-of-Concept Trial. (12th April 2019) Authors: Schweitzer, Paula K; Hauser, Robert A; Amara, Amy W; Videnovic, Aleksandar; Comella, Cynthia; Liu, Kris; Sterkel, Amanda L; Gottwald, Mildred D; Steinerman, Joshua R; Jochelson, Philip; Emsellem, Helene Journal: Sleep Issue: Volume 42(2019)Supplement 1 Page Start: A245 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Α-Synuclein in Parkinson's disease: getting to the core of the matter. Issue 8 (August 2015) Authors: Hauser, Robert A Journal: Lancet neurology Issue: Volume 14:Issue 8(2015:Aug.) Page Start: 785 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗